Gambichler, Thilo <br/><br/>
Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.  [electronic resource] 

 -  Journal for immunotherapy of cancer  10 2018 
 - 113 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-018-0430-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Ipilimumab--adverse effects<br/>Leukocytosis--chemically induced<br/>Melanoma--drug therapy<br/>Nivolumab--adverse effects<br/>Paraneoplastic Syndromes--chemically induced<br/>Skin Neoplasms--drug therapy